Michael E Silverman, PhD

Dr. Michael Silverman is a licensed psychologist and clinician, dual-trained in both psychotherapeutic techniques and cognitive science.

Dr. Silverman has developed numerous novel studies probing the relationship between the brain and behavior. Dr. Silverman also has extensive experience in neuropsychiatric and cognitive assessment. His current research focuses on understanding the neuroanatomical, neurobiological, and neurofunctional basis of mood change during pregnancy and after childbirth. He also has open studies exploring the impact of childhood food allergy on mental health, schizophrenia, the neuropsychiatric influences of Amyotrophic Lateral Sclerosis (ALS; Lou Gehrig's disease), the neuroanatomic effects of chronic stress, and detailing the cognitive changes as the result of in utero dexamethasone treatment secondary to congenital adrenal hypoplasia risk. His work has resulted in numerous peer-reviewed publications, book chapters, public policy positions, and awards.

Dr. Silverman's research portfolio boasts significant milestones, including pioneering the first fMRI study elucidating neural patterns associated with postpartum depression (2007), leading the most extensive population-based study of severe postpartum depression in the United States (2011), co-developing the first validated universal screening program for perinatal mental health in a large hospital network (2016), conducting the largest and most thorough epidemiological analysis of postpartum depression risk factors (2017), detailing obstetric outcomes linked to parental psychiatric history (2023), and identifying autistic spectrum disorders associated with postpartum diagnoses in gestational and non-gestational parents (2024).

Dr. Silverman's clinical expertise and training includes:
• Acceptance and Commitment Therapy (ACT) 
• Cognitive Behavioral Therapy (CBT)              
• Dialectical Behavioral Therapy (DBT)                        
• Interpersonal Psychotherapy (IPT)
• Rational Emotive Dialectical Behavioral Therapy (RO-DBT)